Table 1. Demographics table.
A :Age, M: Male, CAD: Coronary Artery Disease, AP: Atherosclerotic Plaque, Pre: Premature, UA: Unstable Angina, HLD: Hyperlipidemia, ACS: Acute Coronary Syndrome, ASCL: Atherosclerosis, VC: Validation Cohort, UAP: Unstable Angina Pectoris, SAP: Stable Angina Pectoris, AO : Arteriosclerosis Obliterans
| Serial# | Author, Year, Study Population | Study Population Characteristics | Country | Type of Study | Outcome |
| 1 | Diehl, et al.,2011 [8]; CAD (n=5), ACS (n=5) | CAD: A: 76±2; M: 3 (60%) ACS: A: 66±4; M 5 (100%) | China | Case Control | CAD |
| 2 | Sayed, et al., 2015 [11]; CAD (n=65), Non-CAD (n=32) | CAD: A: 53 (49–57); M: 38 (58.4%) Non-CAD: A: 53 (49–57); M: 16(50%) | China | Case Control | CAD |
| 3 | Sayed, et al., 2015 [12]; CAD (n=37), Non-CAD (n=20) | CAD: A: 72.97 ± 4.28; M: 18 (67.5%) Non-CAD: A: 71.7 ± 5.2, M: 10(50%) | China | Case Control | CAD |
| 4 | Zhou, et al., 2015 [13]; CAD (n=67),Non-CAD (n=67) | CAD: A 64.70± 6.79 M: 43 (64.2%) Non-CAD: A: 63.69± 5.96 M: 32 (47.8%) | China | Case Control | CAD |
| 5 | Liu, et al., 2015 [14];CAD (n=90), Non-CAD (n=70) | Not Given | China | Case Control | CAD |
| 6 | Han, et al., 2015 [15]; CAD (n=32), Non-CAD (n=20) | CAD A: 67±11; M: 32 (100%) Non-CAD: A 62±8; M: 20 (100%) | China | Case Control | CAD |
| 7 | Zhu, et al., 2014 [16];CAD (n=56), Non-CAD (n=54) | Not Given | China | Case Control | CAD |
| 8 | Li, et al., 2013 [17]; Pre-CAD(n=12), Non-CAD (n=12) | Age/Sex matched in pre CAD and Non CAD. | China | Case Control | CAD |
| 9 | Ren, et al., 2013 [18]; CAD (UA) (n=45), Non-CAD (n=37) | CAD (UA): A: 63±12; M: 25 (55.5%) Non-CAD: 59±6, M: 22 (59.4%) | China | Case Control | CAD |
| 10 | Guo, et al., 2012 [19]; HLD+CAD (n=155), non-HLD (n=100) | HLD+CAD: A: 65.3 ± 11.0; M: 105 (67.7%) Non-CAD: A 63.0 ± 10.7; M: 35 (70%) | China | Case Control | CAD |
| 11 | Weber, et al., 2011 [20]; CAD (n=10), Non-CAD (n=15) | Age and sex matched | USA | Case Control | CAD |
| 12 | Sondermeijer, et al., 2011 [21]; Pre CAD (n=40), Non-CAD (n=40) ASCL (n=27), family(n=40) | Age matched and males only; controls > 20 yr younger, sex unknown | Netherlands | Case Control | CAD |
| 13 | Fichtlscherer, et al., 2011 [22];CAD (n=67), Non-CAD (n=31) | Cohort; CAD: A: 67.69 ± 11.07; M: 25 (69.4%) Non-CAD: A: 32.18 ± 8.78Male: 6 (35.3%); VC; CAD: A: 68.06 ± 9.66; M: 21 (68%) Non-CAD: A: 39.28 ± 17.52; M: 5: (36%) | Germany | Case Control | CAD |
| 14 | Taurino, et al., 2010 [23]; CAD (n=12), Non-CAD (n=12) | CAD: A: 66±11; M: 12 (100%) Non-CAD: A: 597; M: 12 (100%) | UK | Case Control | CAD |
| 15 | Hoesktra, et al., 2010 [24]; UAP (n=25), SAP (n=25), Non- CAD (n=20) | Age, sex, ethnically, smoking matched | Norway | Case Control | CAD |
| 16 | Takahashi, et al., 2010 [25]; Stable CAD (n=66), Non-CAD (n=33) | CAD: A: 66.2±9.5, M: 52 (79%) Non-CAD: A: 64.2±10.3, M: 26 (79%) | Japan | Case Control | CAD |
| 17 | Li, et al., 2010 [26]; AO (n=104), Non-AO (n=105) | Age Matched | China | Case Control | CAD |
| 18 | Minami, et al., 2009 [27]; Stable CAD (n=44), Non-CAD (n=22) | CAD: A 66.1±12.8; M: 36 (82%). Non-CAD: A: 64.5 ± 8.5, M: 17 (77%) | Japan | Case Control | CAD |